In addition, it addresses the FDA’s communications With all the applicant, the retention of data that support the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may possibly transfer possession of the SE report back to a brand new applicant and Digital submission with the SE repor